
Shares of medical device maker Solventum SOLV.N down 1.2% to $73.50 post-market after secondary offering news
SOLV launches offering of 8.8 mln shares to be offloaded by 3M MMM.N
Goldman Sachs and BofA are underwriters
MMM owns ~34.37 mln SOLV shares for 19.8% stake, according to a SEC filing
Goldman Sachs and BofA are underwriters for the offering
MMM completed the spin-off its health care business in Apr 2024 and retained a 19.9% stake in what is now SOLV
Shares of SOLV closed up 3.2% at $74.38 on Wed, up nearly 13% YTD
Of 13 analysts covering SOLV, recommendation breakdown is 5 "strong buy" or "buy", 7 "hold" and 1 "sell"; median PT is $85.66, LSEG data reflects